Inhibitors of microsomal prostaglandin E synthase-1 (mPges-1) are in the early phase of clinical development. Deletion of mPges-1 confers analgesia, restrains atherogenesis and fails to accelerate thrombogenesis, while suppressing prostaglandin (PG) E 2 , but increasing biosynthesis of prostacyclin (PGI 2 ). In hyperlipidemic mice, this last effect represents the dominant mechanism by which mPges-1 deletion restrains thrombogenesis, while suppression of PGE 2 accounts for its anti-atherogenic effect. However, the impact of mPges-1 depletion on blood pressure (BP) in this setting remains unknown.
Introduction
Both the adverse cardiovascular events associated with non-steroidal anti-inflammatory drugs (NSAIDs) and the opioid crisis have prompted interest in developing new analgesics (1) (2) (3) (4) .
Several clinical trials have shown that the incidence and severity of hypertension from NSAID use is quite variable in humans (5) (6) (7) (8) . Inhibitors of the microsomal PGE synthase -1 (mPGES-1), an enzyme involved in the biosynthesis of prostaglandin (PG) E 2 , are in early clinical development as potential non-addictive analgesics devoid of the cardiovascular hazards attributable to inhibition of cyclooxygenase-2 (COX-2) by NSAIDs.
Deletion of mPges-1 has a mild adverse cardiovascular profile in normolipidemic mice (3) and
we have reported that rediversion of the mPGES-1 substrate prostaglandin (PG)H 2 to prostacyclin (PGI 2 ) synthase, augmenting PGI 2 , attenuates thrombogenesis in hyperlipidemic mice (9) . This is a point of distinction from Cox-2 depletion or inhibition that suppresses synthesis of this endogenous platelet inhibitor and predisposes mice to thrombogenic stimuli (3) .
The sexual dimorphism in blood pressure (BP) homeostasis is at least partly explained by the endocrine system. For example, systolic blood pressure (SBP) is higher in boys from 13 years on compared with girls of the same age (10) and the hypertensive response to salt loading is more pronounced in apparently healthy males compared to premenopausal females at different ages (11) . Similarly, in genetically and experimentally predisposed rodent models, hypertension develops more slowly in female than in male mice (12, 13) . Deletion of prostaglandin E 2 receptor, Epr1, reduced BP in male but not female mice (14) .
Here, the BP response to a high salt diet (HSD) is augmented in hyperlipidemic mice lacking the low-density lipoprotein receptor (Ldlr). Both PGE 2 and PGI 2 may act as direct vasodilators so we assumed that exaggeration of this response in mPges-1 mice was attributable to suppression of PGE 2 , despite their augmented formation of PGI 2 . To our surprise, deletion of the Ipr attenuated the hypertensive response to mPges-1 deletion. Furthermore, this was observed in male, but not female mice. Mechanistically, we found that Ipr deletion results in a release of the vasodilator, atrial natriuretic peptide (ANP) (15, 16) and attenuation of the oxidant stress that characterizes hyperlipidemia (17) in male mice. This results in abrogation of the hypertensive response to salt.
In females, by contrast, these responses were not observed, while in ovariectomized mice estrogen attenuated salt-evoked hypertension in both Ldlr KO and Ipr/Ldlr DKO but not in mPges-1/Ldlr DKO mice.
Results

Deletion of the Ipr in mPges-1-deficient hyperlipidemic mice abrogates salt-evoked hypertension
Hyperlipidemic mice (Ldlr KO) were used in the current study to simulate more closely the atherosclerosis likely extant in elderly patients targeted for analgesia with mPGES-1 inhibitors. Figures 1A-1D , despite feeding a chow diet, plasma cholesterol and/ or triglyceride levels of Ldlr KO, Ipr-and mPges-1-deficient Ldlr DKO mice were significantly elevated.
As shown in Supplemental
Male Ldlr KOs fed a HSD showed a time-dependent elevation of SBP in the active (night) period ( Figure 1A-1B ). The SBP was significantly elevated in week 2 compared with baseline during the active phase. Deletion of mPges-1 significantly increased further the salt-evoked BP response. By contrast, deletion of the Ipr unexpectedly restrained the hypertensive response to the HSD in both Ldlr KOs and mice also lacking mPges-1. At baseline, male mice lacking both mPges-1 and Ldlr had elevated BP compared to the other genotypes ( Figure 1 ). Thereafter the attenuating effects of Ipr deletion became apparent: SBPs of Ldlr KO, mPges-1/Ldlr DKO and Ipr/mPges-1/Ldlr TKO mice were significantly elevated compared with Ipr/Ldlr DKOs one week and/ or two weeks after feeding them the HSD. Similar differences in diastolic blood pressure (DBP) responses were observed in all mutants and their littermate controls fed a HSD in the active and resting periods ( Figure 1C -1D). DBP in Ldlr KOs was significantly elevated at week 2 compared with baseline during the active phase. Compared with Ipr/Ldlr DKO, the DBPs of Ldlr KO, mPges-1/Ldlr DKO and Ipr/mPges-1/Ldlr TKO mice were significantly elevated at baseline, one week and/ or two weeks after HSD feeding. However, these HSD evoked BP responses were not observed in female hyperlipidemic mice (Supplemental Figure 2A-2D ). In addition, weight gain, urinary output/ fluid intake ratio and urinary sodium levels did not appear to explain the sex differences in BP responses to the salt loading in our mice (Supplemental Figure 3A -3C). We were not able to measure accurately food intake in the current study because the HSD was very hygroscopic.
Detailed statistical analyses of the interactions among genotypes, treatment (week) and phases for both sexes are described in supplemental Figure 4 .
Impact of Ipr and mPges-1 deletion on prostaglandin biosynthesis in male hyperlipidemic mice on a high salt diet
Two weeks of HSD feeding suppressed PGE 2 but increased PGI 2 biosynthesis in male Ldlr KO mice, as reflected in their urinary PGEM (7-hydroxy-5, 11-diketotetranorprostane-1, 16-dioic acid) and PGIM (2, 3-dinor 6-keto PGF 1α ) metabolites, respectively (Figure 2A -2B). Overall ( Figure 2 ), deletion of mPges-1 in the hyperlipidemic mice (mPges-1/Ldlr DKO) suppressed PGE 2 and augmented formation of PGI 2 , thromboxane (Tx)B 2 and PGD 2 as expected consequent to substrate rediversion. These changes were more pronounced on the HSD. Finally, deletion of the Ipr resulted in a reactionary increase in biosynthesis of PGI 2 , but also TxB 2 and PGD 2 , again apparent on an HSD.
Detailed statistical analyses of the interactions among urinary prostaglandin metabolites, genotypes and treatment (week) are described in supplemental Figure 5 .
Pharmacological inhibition of the human mPGES-1 enzyme elevates systolic blood pressure in hyperlipidemic male mice
To confirm the hypertensive phenotype of global mPges-1/Ldlr DKOs, an mPGES-1 inhibitor (MF970, 10 mg/Kg BW) was administered concomitantly with a high fat diet (HFD) for 39 weeks in humanized mPGES-1 Ldlr KO male mice. As shown in Supplemental Figure 6 , inhibition of mPGES-1 suppressed urinary PGEM (A) and elevated SBP response (B) as compared to control with the HFD alone.
A HSD activates atrial natriuretic peptide synthesis and release in Ipr-deficient mice
The unexpected suppression of the salt-evoked elevation of BP by Ipr deletion prompted us to compare gene expression profiles in the renal medullae of male Ldlr KOs and Ipr/Ldlr DKOs by high throughput RNA sequencing. We identified 897 differentially expressed genes (DEGs), with a log fold change ranging from 2.76 and -3.07 between Ldlr KO and Ipr/Ldlr DKOs at a false discovery rate cutoff of 0.033. Four hundred and forty five of these 897 DEGs were upregulated and 452 were downregulated in the renal medulla of Ipr/Ldlr DKOs compared to Ldlr KOs. Ingenuity Pathway analysis (IPA) was used to assess changes in biological pathways associated with gene expression (Table 1 ) and the pathways most enriched with DEGs included eukaryotic initiation factor (eIF2), eIF4/ p70S6K and mTOR signaling, mitochondrial dysfunction and oxidative phosphorylation. Thirty five of the 44 identified genes in the eIF2 pathway were downregulated in the Ipr/Ldlr DKOs, mostly members of the 60s and 40s ribosomal subunits involved in RNA binding ( Figure 3A and Supplemental Table 1 ). Twenty three of 24 genes related to mitochondrial dysfunction and oxidative phosphorylation were downregulated in the Ipr/Ldlr DKOs ( Figure 3A and Supplemental Table 1 Figure 3B ). We confirmed by RT-qPCR analyses that mRNA levels of corin (ANP-converting enzyme) and ANP, but not brain natriuretic peptide (BNP), were significantly increased in whole heart lysate in Ipr/Ldlr DKOs ( Figure 3C -3E). Moreover, renal medullary expression of Npr1, a receptor of ANP, was significantly increased ( Figure 3F ). Consistent with the gene expression data, urinary ANP levels were also elevated in Ipr/Ldlr DKOs compared with Ldlr KOs after two weeks on the HSD ( Figure 4A -4B). We did not observe a significant difference in creatinine levels in the urine samples between Ldlr KOs and Ipr/Ldlr DKO mutants (Supplemental Figure 3D ). Thus, elevated urinary ANP levels were not likely to be confounded by differences in fluid intake.
Consistent with the role of PGI 2 in restraining oxidative stress in atherosclerotic vasculature (18) and in salt-induced hypertension (19, 20) and the elevation of PGI 2 biosynthesis on the HSD (Figure 2 ), excretion of a major urinary F 2 -isoprostane (F 2 iP), an index of lipid peroxidation, was not significantly elevated in Ldlr KOs after 2 weeks on a HSD ( Figure 4C and 4D). However, rather than increase with Ipr deletion, F 2 iP excretion, just like BP, unexpectedly fell, consistent with the changes in mitochondrial dysfunction and oxidative phosphorylation genes observed in the renal medulla of Ipr/Ldlr DKO mice (mostly downregulated in the Ipr/Ldlr DKO) ( Figure   4D ). The reduction in urinary F 2 iP and elevated ANP levels consequent to Ipr deletion in the Ldlr KOs was abrogated by treatment with the ANP receptor antagonist, A71915 (21-23) ( Figure   4E and 4F). This is consistent with evidence that ANP is both a vasodilator and a restraint on oxidative stress (22, 24) . Figure 12B ). However, combined deletion of Ipr and ANP receptor blockade in females significantly increased urinary F 2 iPs (Supplemental Figure 12C ), while deletion of the Ipr significantly reduced baseline urinary ANP (Supplemental Figure 12D ). This difference was abolished after two weeks on the HSD (Supplemental Figure 12E) ; blockade of the ANP receptor did not alter ANP levels between Ldlr KO and Ipr/Ldlr DKOs (Supplemental Figure 12F ). These results were consistent with the failure of genotype to influence significantly the HSD evoked BP response in female mice (Supplemental Figure 2 ).
An atrial natriuretic peptide antagonist rescues hypotension in Ipr-deficient hyperlipidemic mice on a high salt diet
Due to the physiological constraint of implanting both radio telemetry probes and mini-pumps in mice for monitoring BP and delivering the ANP antagonist during HSD feeding, we decided to use the tail-cuff system for the former while delivering the antagonist by mini-pumps. Despite being less sensitive, BP data collected with the tail-cuff system correlate with those from radio telemetry ( Figure 5A 
Detailed statistical analyses of the interactions between BP, genotypes and treatment (week) in
A71915 study in male mice are described in Supplemental Figure 17 .
Estrogen protects female hyperlipidemic mice from salt-evoked hypertension
To address the female BP phenotypes, we performed the HSD experiment using ovariectomized 
Discussion
NSAIDs represent one of the few alternatives to opioid analgesics but themselves confer a cardiovascular hazard attributable to suppression of COX-2 derived cardioprotective prostaglandins, especially PGI 2 (25) . PGI 2 restrains platelet activation and is a vasodilator; deletion of its Ipr receptor predisposes normolipidemic mice to thrombogenic and hypertensive stimuli (3, 26, 27) . Given the importance of PGE 2 as a mediator of pain and inflammation, interest has focused on the development of inhibitors of mPGES-1, the enzyme downstream of COX-2 that is the dominant source of PGE 2 biosynthesis (1, 2).
In normolipidemic mice, deletion of mPges-1, unlike deletion of Cox-2 or the Ipr, has a bland adverse cardiovascular profile; it does not promote thrombogenesis and it restrains atherogenesis (3, 28) . This reflects rediversion of the PGH 2 substrate of mPGES-1 to other PG synthases, most relevantly to augment PGI 2 biosynthesis (29) . Depending on genetic background, it may leave basal and evoked BP responses unchanged or modestly increased. On a hyperlipidemic background, increased PGI 2 limited thrombogenesis while suppression of PGE 2 accounted for restraint of atherogenesis when mPges-1 was deleted (9) . Inhibition of mPGES-1 in humans also augments biosynthesis of PGI 2 coincident with suppression of PGE 2 (30) .
Initially, we wished to examine the impact of mPges-1 deletion on BP in hyperlipidemic mice.
Both PGE 2 and PGI 2 may act as vasodilators and deletion of their Epr2 and Ipr receptors predisposed normolipidemic mice to HSD induced elevations of BP (26, 27, 31) . Here, we found that mPges-1 deletion predisposed hyperlipidemic male, but not female mice, to the pressor response to HSD, consistent with the role of PGE 2 in fluid volume and BP homeostasis (32) .
Moreover, chronic exposure to a pharmacological inhibitor (MF970) specifically targeting human mPGES-1 resulted in elevated SBP in hyperlipidemic mice on a HFD. These observations raise the possibility that despite results in healthy volunteers (28) , inhibition of mPGES-1 in male patients with hyperlipidemia may predispose them to an exaggerated BP response to a HSD.
To investigate whether the augmented PGI 2 biosynthesis resulting from mPges-1 deletion might be buffering the hypertensive phenotype we utilized mice lacking the Ipr. We were surprised to find that BP responses to salt loading in male, but not female mice, was attenuated (rather than exacerbated) in Ipr/mPges-1 DKOs. Deletion of the Ipr resulted in a compensatory increase in biosynthesis of PGI 2 consequent to salt loading. However, given the absence of its receptor, this would be unlikely to influence directly BP homeostasis. Rather, we found activation of another compensatory mechanism, increased formation of the vasodilator ANP. Antagonism of its Npr1 receptor was sufficient to rescue the hypotensive response to a HSD in Ipr depleted mice.
Hyperlipidemia in Ldlr KOs is associated with oxidative stress, reflected by increased generation of F 2 iPs, biomarkers of lipid peroxidation (17) . Both PGI 2 and ANP can act to restrain oxidative stress which itself may contribute to elevation of BP in response to a HSD (18, 33, 34) . Here we found that despite augmented biosynthesis of PGI 2 , urinary F 2 iP was depressed in Ipr/Ldlr DKOs compared to mice lacking the Ldlr alone. To address the possibility that this reflected the compensatory augmentation of ANP, we treated the mice with an ANP receptor antagonist and found that like the hypotensive phenotype, it rescued the suppression of These differences in the BP response to a HSD and the attendant changes in gene expression and activation of the ANP pathway were observed only in male mice. There is prior evidence for the influence of sex and genetic background on disruption of the prostaglandin pathways. For example, we have shown that deletion of the Ipr accelerates atherogenesis particularly in female mice due to the importance of PGI 2 as a mediator of estrogen receptor dependent cardioprotection (18) .
Estrogen increases vasodilation partly by binding to its receptors in vascular endothelial and smooth muscle cells (SMC) of the vasculature (37) . Consistent with the findings that estradiol activates PGI 2 biosynthesis in rat aortas (38) , rat aortic SMC (39) and human endothelial cells In summary, we report distinct sex dependent compensatory mechanisms to preserve BP homeostasis in response to disruption of the receptor for the direct vasodilator, PGI 2 ( Figure 6 ).
In males, deletion of the Ipr restrains salt-evoked hypertension via activation of the ANP/Npr1 pathway reducing the oxidative stress characteristic of hyperlipidemia. In female mice, estrogen restrains the BP responses of both Ldlr KO and Ipr/Ldlr DKO mice to salt-evoked hypertension.
Additionally, our findings with mPges-1 deletion or pharmacological inhibition of the enzyme in mice suggest that hyperlipidemic male patients, consuming a high salt diet, will be susceptible to hypertension when taking mPGES-1 inhibitors.
Methods
All reagents used were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated.
Generation of prostacyclin receptor knockout (Ipr KO) and microsomal prostaglandin E synthase-1 knockout (mPges-1 KO) hyperlipidemic mice
Ipr and mPges-1 KOs were generated on a hyperlipidemic background by crossing them with mice lacking the low-density lipoprotein receptor (Ldlr KOs on C57BL/6 background-Jackson Laboratory) that were inter-crossed to breed Ipr +/-/mPges-1 +/-/Ldlr KOs. The heterozygous mice were intercrossed to produce Ldlr KOs, Ipr/Ldlr DKOs, mPges-1/Ldlr DKOs, and Ipr/mPges-1/Ldlr TKOs. Loss of Ipr, mPges-1 and Ldlr alleles were assessed by PCR analyses.
Single nucleotide polymorphism (SNP) analyses showed that our mouse models achieved at least 97% purity on the C57BL/6 background. Mice of both genders were fed a high salt diet (HSD, 8% NaCl, TD.92012, Harlan Teklad, Madison, WI) and saline containing 0.9% NaCl (Hospira, Lake Forest, IL) from 8-10 weeks of age for two weeks. Mice were weighed before and after the HSD feeding. All animals in this study were housed according to the guidelines of the Institutional Animal Care and Use Committee (IACUC) of the University of Pennsylvania. All experimental protocols were approved by IACUC (protocol #804754).
Blood pressure measurement using radio telemetry
Continuous 24-h systolic and diastolic BPs were monitored in free running mice with the Dataquest IV systems (Data Science) as described previously.(41) Briefly, after recovering from surgery, mice were kept in a 12-hour light/ dark cycle and fed a normal chow diet (0.6% NaCl).
During that time, baseline systolic and diastolic BPs, heart rate and locomotor activity of mice were measured continuously for 2-3 days. After switching to a HSD, BP was again measured continuously from day 5-7 and from day 12-14. All data are expressed as averages of 12-h day or Figure 20) .
12-h night recordings (Supplemental
Fluid intake and urinary output
One week after HSD feeding, mice were housed in metabolic cages starting from 7 am for habituation in a 12-h light/ dark cycle housing facility. At 7 pm, fluid intake and urine production were recorded every 12-h for 48 hours while HSD and saline were provided ad libitum. Urine samples were pooled and reported as ml/g BW/day. An enrichment toy (42) was provided in each cage during the entire period.
Blood pressure measurement using at tail-cuff system during HSD administration with an atrial natriuretic peptide receptor antagonist (A71915) Systolic blood pressure (SBP) was measured in conscious mice using a computerized, noninvasive tail-cuff system (Visitech Systems, Apex, NC) as described (3, 9) . In male mice, BP was recorded twice each day from 7 to 9 am and 7 to 9 pm for 2-3 consecutive days after 3 days of training. In female mice, BP was recorded once each day from 7 to 9 am for 3 consecutive days after 3 days of training. Averaged SBPs were reported. Atrial natriuretic peptide receptor antagonist (A71915, 50µg/Kg BW/day, H-3048, Bachem California, Torrance, CA) was dissolved in saline and delivered via minipumps in mice during HSD feeding period. A71915 was shown to inhibit cGMP response by 3 orders of magnitude in in vitro studies (21) and attenuated hypertension and cardiac hypertrophy in 2K1C rats with prolonged exposure to nimesulide or NS-398 (COX-2 inhibitors) via the activation of ANP signaling pathway (22) .
Pharmacological inhibition of mPGES-1 enzyme in humanized mPges-1 hyperlipidemic mice
Male mice with knock in of human mPges-1 were crossed with Ldlr KO mice and commenced at 8 weeks of age were fed a high fat diet (Harlan Teklad, TD 88137) for 39 weeks alone and in combination with a specific inhibitor of mPGES-1 (MF970, 10 mg/ Kg BW; a kind gift of Merck). BP was measured using the tail-cuff system as mentioned. Urinary prostanoid metabolites were measured by liquid chromatography/ mass spectrometry as described. Most pharmacological inhibitors of human mPGES-1 fail to engage the murine enzyme (43)
Mass spectrometric analysis of prostanoids and isoprostanes
Urinary prostanoid metabolites were measured by liquid chromatography / mass spectrometry as described (44) . Such measurements provide a noninvasive, time integrated measurement of systemic prostanoid biosynthesis (45) . Briefly, mouse urine samples were collected using metabolic cages over an 8 hour period (9am to 5pm). Systemic production of PGI 2 , PGE 2 , PGD 2 , and TxA 2 was determined by quantifying their major urinary metabolites-2, 3-dinor 6-keto PGF 1α (PGIM), 7-hydroxy-5, 11-diketotetranorprostane-1, 16-dioic acid (PGEM), 11, 15-dioxo-9 α -hydroxy-2, 3, 4, 5-tetranorprostan-1, 20-dioic acid (tetranor PGDM) and 2, 3-dinor TxB 2 (TxM), respectively. For isoprostanes (iPs), the most abundant iPs detected in urine, 8,12-iso-iPF 2α -VI was measured (46) . Results were normalized with urinary creatinine.
Mass spectrometric analysis of plasma or urinary creatinine
Quantitation of plasma or urinary creatinine was performed using ultra high pressure liquid 
Urinary atrial natriuretic peptide, total nitrate+nitrite and sodium levels and plasma renin level
Atrial natriuretic peptide (Arbor Assays, K026-H1, Ann Arbor, MI), total nitrate+nitrite (Cayman Chemical, 780001, Ann Arbor, MI) and sodium (Biovision, K391-100, Milpitas, CA) levels in mouse urine and plasma renin levels (Abcam, ab138875, Cambridge, MA) were measured following manufacturer's instructions.
Preparation of mouse heart and kidney medulla for real-time PCR analysis of gene expression
Briefly, heart and kidney medulla were collected from animals perfused with ice-cold PBS dissolved in UltraPure TM DEPC-treated water to minimize degradation of RNA. The tissues were immediately stored separately in RNAlater® solution (Ambion, Austin, TX) at 4ºC. After 24h, the tissue samples were transferred to -80ºC for storage until analyses. RNA was extracted using Results were normalized to HPRT (Mm01545399_m1).
RNA sequencing and analysis
Total RNA from mouse kidney medulla was isolated using Trizol and Qiagen RNeasy and RNA integrity was checked on an Agilent Technologies 2100 Bioanalyzer. RNA-seq of 16 
Ovariectomy
Female mice at eight weeks old were bilaterally ovariectomized following procedures as described by Souza et al (48) . For the 17β-estradiol (E2) study, mice recovered from the surgery were given E2 (150nM) in saline drinking fluid before feeding a HSD for 2 weeks. During the feeding period, the concentration of E2 was reduced to 100nM due to the increase in fluid consumption (49) .
Haemotoxylin and eosin staining of kidney and aortic roots
Kidneys (n=4) and aortic roots (n=3) were formalin fixed and paraffin embedded, and 5 µm serial sections (6-10 sections) of the tissues were cut and mounted on Superfrost Plus slides for analysis of tissue morphology by HE staining.
Statistics
All animals were the same age and on the same LdIr KO background (C57BL/6). Where conclusions involve multiple factors, two-, three-and four-way ANOVA with repeated measures was used to investigate changes in mean scores at multiple time points and differences in mean scores under multiple conditions. The residuals are normally distributed as required by ANOVA.
The degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity.
ANOVA tests were repeated on multiple restricted models to investigate combinations of factors' effects. Post-hoc analysis was performed by pairwise t-tests, with Bonferroni correction unless otherwise stated. A significance threshold of 0.05 was used for all tests. Significance of greater than 0.01 is indicated by double-asterisks on the graphs and significance greater than per genotype). We used a one-tailed test for urinary F 2 iP and ANP because both mediators had been already shown to restrain oxidative stress in the vasculature. 
